Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Cent Afr J Med ; 60(9-12): 56-62, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-26867256

RESUMEN

BACKGROUND: Co-infections have become significant causes of morbidity and mortality in Human Immunodeficiency Virus (HIV) infected people. Due to shared routes of transmission, co-infection of HIV with Hepatitis B (HBV) and/or Hepatitis C (HCV) should be expected. In Zimbabwe, screening for both viruses in HIV infected people prior to treatment is not routinely practised despite the World Health Organisation (WHO) guidelines (2013) prioritising treatment where these co-infections exist. OBJECTIVE: To determine the prevalence of HBV and HCV infection in HIV infected adults at a public sector HIV clinic in Zimbabwe and to determine risk factors associated with these infections. DESIGN AND SETTING: An analytical cross-sectional survey carried out among systematically randomly sampled HIV infected patients coming for treatment between March and July 2012 at Parirenyatwa Hospital Opportunistic Infection Clinic. MATERIALS AND METHODS: Blood samples were tested for hepatitis B surface antigen (HBsAg) and hepatitis C virus antibodies (anti-HCV). Demographic data and exposure to risk factors were collected. RESULTS: 228 antiretroviral therapy (ART) naive adults were enrolled. 7.9% (18/228) were HBsAg positive and 0.9% (2/228) were anti-HCV positive. None of the participants were infected with both viruses. CONCLUSIONS: The prevalence of HBV has not changed during this HIV era and there is no significant HCV infection in this public sector clinic which serves quite a large sector of the population that lives in Harare, Zimbabwe. Based on these results, there is no need for HCV screening but HBV screening prior to ART initiation may be required. -


Asunto(s)
Coinfección/epidemiología , Infecciones por VIH/complicaciones , Hepatitis B/epidemiología , Hepatitis C/epidemiología , Adolescente , Adulto , Coinfección/diagnóstico , Estudios Transversales , Femenino , Hepatitis B/diagnóstico , Hepatitis C/diagnóstico , Hospitales Públicos , Humanos , Masculino , Servicio Ambulatorio en Hospital , Prevalencia , Adulto Joven , Zimbabwe
2.
Cent Afr J Med ; 59(5-8): 38-42, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-29144618

RESUMEN

Objective: To determine blood glucose levels by conducting an oral glucose tolerance test in low and normal birth weight young black adults. Design: Acase control study was done. Seventy students in the College of Health Sciences who had neonatal clinic cards as proof of birth weight were recruited into the study. Blood glucose levels were measured before, during and after the oral glucose tolerance test. Setting: Department of Physiology, University of Zimbabwe, College of Health Sciences, Harare, Zimbabwe. Main Outcome Measures and Results: A total of 70 young adult participants, 47(67%) females and 23(33%)males with mean age 20.28±0.19 years were recruited. 30 had Low Birth Weight (LBW, 21 females and 9 males) and 40 had Normal Birth Weight (NBW,26 females and 14 males).LBW individuals had significantly elevated (p<0.05) mean blood glucose levels at 30minutes(9.41±0.91 for LBW and 7.24±0.28 for NBW, p=0.029) and 60 minutes (9.22±0.75 for LBW and 7.57±0.36 for NBW, p=0.035) after the oral glucose tolerance test. Oral glucose tolerance testing detected 1case of type II diabetes (LBW individual), 13cases of impaired glucose tolerance (9 LBW and 4 NBW individuals)and 1 case of impaired fasting glucose (LBW individual).LBW was associated with an odds ratio of 3.1 for impaired glucose tolerance and it was statistically significant, p<0.05 (p=0.027). Conclusion: Low birth weight was associated with glucose intolerance and significantly higher mean blood glucose levels at 30 and 60 minutes after glucose loading in young adults.


Asunto(s)
Población Negra , Glucemia/metabolismo , Diabetes Mellitus Tipo 2/diagnóstico , Intolerancia a la Glucosa/diagnóstico , Peso al Nacer , Estudios de Casos y Controles , Femenino , Intolerancia a la Glucosa/epidemiología , Intolerancia a la Glucosa/etiología , Prueba de Tolerancia a la Glucosa , Humanos , Recién Nacido de Bajo Peso , Recién Nacido , Masculino , Adulto Joven , Zimbabwe
3.
Cent Afr J Med ; 58(9-12): 33-8, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-26255327

RESUMEN

OBJECTIVE: To compare the prices charged for clinical laboratory tests in Zimbabwean institutions with those of similar institutions abroad. DESIGN: An online analytical cross sectional study was conducted. SETTING: An online survey. SUBJECTS: We did an online survey of clinical laboratories that published prices of the tests offered on their websites. We also extracted price information from documents published by fees regulatory authorities. MAIN OUTCOME MEASURES: Laboratory test prices for independent institutions, Laboratory test prices for State institutions. RESULTS: Overally for all countries, laboratory test prices were lower in state laboratories compared to the independent laboratories. In Zimbabwe, state laboratories generally charged about 50% of the independent laboratory tariff for most tests. However prices from both Zimbabwean institutions were generally much higher than those of the comparison countries (United Kingdom, South Africa, India, United States of America and New Zealand). CONCLUSION: Prices of laboratory tests are indeed higher in Zimbabwean institutions compared to other centres abroad. These higher prices could be attributed to challenges in consumable procurement logistics. We also present measures that could be put in place to reduce the costs and therefore prices.


Asunto(s)
Servicios de Laboratorio Clínico/economía , Técnicas de Laboratorio Clínico/economía , Costos y Análisis de Costo/estadística & datos numéricos , Estudios Transversales , Humanos , Zimbabwe
4.
Int J Tuberc Lung Dis ; 13(10): 1267-73, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19793432

RESUMEN

OBJECTIVE: To evaluate human immunodeficiency virus (HIV) serology, dietary iron and serum concentrations of markers of T-helper type (Th) 1 and Th-2 immune pathways in the setting of tuberculosis (TB). METHODS: A total of 49 patients with pulmonary TB in rural Zimbabwe, 32 of whom were HIV-positive, were evaluated at presentation and over 10 weeks of anti-tuberculosis treatment. RESULTS: Interleukin (IL) 12 and neopterin, Th-1 markers, were both elevated at presentation in 92% of the subjects. In contrast, only 23% had elevation of the Th-2 marker, IL-4. Neopterin and IL-6 concentrations decreased over 10 weeks of treatment (P

Asunto(s)
Seropositividad para VIH/complicaciones , Células TH1/inmunología , Células Th2/inmunología , Tuberculosis Pulmonar/inmunología , Adulto , Antituberculosos/uso terapéutico , Citocinas/inmunología , Femenino , Humanos , Hierro de la Dieta/efectos adversos , Masculino , Persona de Mediana Edad , Nitratos/metabolismo , Nitritos/metabolismo , Factores de Riesgo , Tuberculosis Pulmonar/tratamiento farmacológico , Tuberculosis Pulmonar/etiología , Adulto Joven , Zimbabwe
5.
Blood Cells Mol Dis ; 31(3): 299-304, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14636642

RESUMEN

The product of the SLC40A1 gene, ferroportin 1, is a main iron export protein. Pathogenic mutations in ferroportin 1 lead to an autosomal dominant hereditary iron overload syndrome characterized by high serum ferritin concentration, normal transferrin saturation, iron accumulation predominantly in macrophages, and marginal anemia. Iron overload occurs in both the African and the African-American populations, but a possible genetic basis has not been established. We analyzed the ferroportin 1 gene in 19 unrelated patients from southern Africa (N = 15) and the United States (N = 4) presenting with primary iron overload. We found a new c. 744 C-->T (Q248H) mutation in the SLC40A1 gene in 4 of these patients (3 Africans and 1 African-American). Among 22 first degree family members, 10 of whom were Q248H heterozygotes, the mutation was associated with a trend to higher serum ferritin to amino aspartate transferase ratios (means of 14.8 versus 4.3 microg/U; P = 0.1) and lower hemoglobin concentrations (means of 11.8 versus 13.2 g/dL; P = 0.1). The ratio corrects serum ferritin concentration for alcohol-induced hepatocellular damage. We also found heterozygosity for the Q248H mutation in 7 of 51 (14%) southern African community control participants selected because they had a serum ferritin concentration below 400 microg/L and in 5 of 100 (5%) anonymous African-Americans, but we did not find the change in 300 Caucasians with normal iron status and 25 Caucasians with non-HFE iron overload. The hemoglobin concentration was significantly lower in the African community controls with the Q248H mutation than in those without it. We conclude that the Q248H mutation is a common polymorphism in the ferroportin 1 gene in African populations that may be associated with mild anemia and a tendency to iron loading.


Asunto(s)
Población Negra/genética , Negro o Afroamericano/genética , Proteínas de Transporte de Catión/genética , Sobrecarga de Hierro/genética , Mutación/genética , Secuencia de Bases , Femenino , Ferritinas/sangre , Glutamina/genética , Glutamina/metabolismo , Pruebas Hematológicas , Histidina/genética , Histidina/metabolismo , Humanos , Hierro/sangre , Sobrecarga de Hierro/sangre , Persona de Mediana Edad , Datos de Secuencia Molecular , Polimorfismo Genético/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...